A Unicentric, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Melatonin as an Adjunct in Patients With Acute myocaRdial Infarction Undergoing Primary Angioplasty
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melatonin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms MARIA
- 22 Jul 2020 Biomarkers information updated
- 03 Jan 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Sep 2013 Planned end date changed from 1 Nov 2014 to 1 Nov 2015 as reported by ClinicalTrials.gov.